Patents by Inventor Chong-Hwan Chang

Chong-Hwan Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES
    Publication number: 20240024356
    Abstract: The invention relates to method of treating chronic inflammatory diseases in subjects in need thereof by administering calcium lactate as an active agent. The calcium lactate can be provided in a pharmaceutical, food, or nutrient composition.
    Type: Application
    Filed: September 11, 2023
    Publication date: January 25, 2024
    Applicant: METIMEDI PHARMACEUTICALS CO., LTD.
    Inventors: Chong-Hwan CHANG, Keun-Yeong JEONG
  • METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES
    Publication number: 20230302046
    Abstract: The invention relates to method of treating chronic inflammatory diseases in subjects in need thereof by administering calcium lactate as an active agent. The calcium lactate can be provided in a pharmaceutical, food, or nutrient composition.
    Type: Application
    Filed: May 9, 2023
    Publication date: September 28, 2023
    Applicant: METIMEDI PHARMACEUTICALS CO., LTD.
    Inventors: Chong-Hwan CHANG, Keun-Yeong JEONG
  • Methods of treating chronic inflammatory diseases
    Patent number: 11684635
    Abstract: The invention relates to method of treating chronic inflammatory diseases in subjects in need thereof by administering calcium lactate as an active agent. The calcium lactate can be provided in a pharmaceutical, food, or nutrient composition.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: June 27, 2023
    Assignee: METIMEDI PHARMACEUTICALS CO., LTD.
    Inventors: Chong-Hwan Chang, Keun-Yeong Jeong
  • CALCIUM LACTATE COMPOSITIONS AND METHODS OF USE
    Publication number: 20220175706
    Abstract: The invention relates to pharmaceutical compositions comprising calcium lactate as an active agent and a polysaccharide, polymer, lipid, or a combination thereof. The pharmaceutical compositions are useful treating cancer. The invention also relates to foods and nutrient compositions comprising calcium lactate.
    Type: Application
    Filed: February 24, 2022
    Publication date: June 9, 2022
    Applicant: METIMEDI PHARMACEUTICALS CO., LTD.
    Inventors: Chong Hwan CHANG, Keun-Yeong Jeong
  • Calcium lactate compositions and methods of use
    Patent number: 11285121
    Abstract: The invention relates to pharmaceutical compositions comprising calcium lactate as an active agent and a polysaccharide, polymer, lipid, or a combination thereof. The pharmaceutical compositions are useful treating cancer. The invention also relates to foods and nutrient compositions comprising calcium lactate.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: March 29, 2022
    Assignee: MetiMedi Pharmaceuticals Co., Ltd.
    Inventors: Chong Hwan Chang, Keun-Yeong Jeong
  • METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES
    Publication number: 20210106614
    Abstract: The invention relates to method of treating chronic inflammatory diseases in subjects in need thereof by administering calcium lactate as an active agent. The calcium lactate can be provided in a pharmaceutical, food, or nutrient composition.
    Type: Application
    Filed: December 23, 2020
    Publication date: April 15, 2021
    Applicant: METIMEDI PHARMACEUTICALS CO., LTD.
    Inventors: Chong-Hwan CHANG, Keun-Yeong JEONG
  • Methods of treating chronic inflammatory diseases
    Patent number: 10898514
    Abstract: The invention relates to method of treating chronic inflammatory diseases in subjects in need thereof by administering calcium lactate as an active agent. The calcium lactate can be provided in a pharmaceutical, food, or nutrient composition.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: January 26, 2021
    Assignee: MetiMedi Pharmaceuticals Co., Ltd.
    Inventors: Chong-Hwan Chang, Keun-Yeong Jeong
  • METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES
    Publication number: 20200352988
    Abstract: The invention relates to method of treating chronic inflammatory diseases in subjects in need thereof by administering calcium lactate as an active agent. The calcium lactate can be provided in a pharmaceutical, food, or nutrient composition.
    Type: Application
    Filed: July 29, 2020
    Publication date: November 12, 2020
    Applicant: METIMEDI PHARMACEUTICALS CO., LTD.
    Inventors: Chong-Hwan CHANG, Keun-Yeong JEONG
  • Methods of treating chronic inflammatory diseases
    Patent number: 10751365
    Abstract: The invention relates to method of treating chronic inflammatory diseases in subjects in need thereof by administering calcium lactate as an active agent. The calcium lactate can be provided in a pharmaceutical, food, or nutrient composition.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: August 25, 2020
    Assignee: MetiMedi Pharmaceuticals Co., Ltd.
    Inventors: Chong-Hwan Chang, Keun-Yeong Jeong
  • CALCIUM LACTATE COMPOSITIONS AND METHODS OF USE
    Publication number: 20190307712
    Abstract: The invention relates to pharmaceutical compositions comprising calcium lactate as an active agent and a polysaccharide, polymer, lipid, or a combination thereof. The pharmaceutical compositions are useful treating cancer. The invention also relates to foods and nutrient compositions comprising calcium lactate.
    Type: Application
    Filed: July 7, 2017
    Publication date: October 10, 2019
    Inventors: Chong Hwan CHANG, Keun-Yeong JEONG
  • METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES
    Publication number: 20190247426
    Abstract: The invention relates to method of treating chronic inflammatory diseases in subjects in need thereof by administering calcium lactate as an active agent. The calcium lactate can be provided in a pharmaceutical, food, or nutrient composition.
    Type: Application
    Filed: January 11, 2019
    Publication date: August 15, 2019
    Inventors: Chong-Hwan Chang, Keun-Yeong Jeong
  • Heteroaryl-Pyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists
    Publication number: 20080081812
    Abstract: A heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The present invention also provides a method for preparing the inventive heteroaryl-pyrasole compounds or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.
    Type: Application
    Filed: September 28, 2007
    Publication date: April 3, 2008
    Applicant: Green Cross Corporation
    Inventors: Jinhwa LEE, Jeong Kim, Chong-Hwan Chang, Suk Lee, Hee Seo, Suk Kang, Kwang-Seop Song, Jong Kim, Min-ah Kim, Sung-han Lee, Kwang-Woo Ahn, Myung Eun Jung, Ji-Hyun Park